LEXICON PHARMACEUTICALS, INC. Quarterly Other Assets, Current in USD from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Lexicon Pharmaceuticals, Inc. quarterly Other Assets, Current history and growth rate from Q4 2010 to Q3 2024.
  • Lexicon Pharmaceuticals, Inc. Other Assets, Current for the quarter ending September 30, 2024 was $6.71M, a 56.3% increase year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $6.71M +$2.42M +56.3% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $7.68M +$1.55M +25.3% Jun 30, 2024 10-Q 2024-08-02
Q1 2024 $7.01M +$3.66M +109% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $5.13M +$2.65M +107% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 $4.29M +$1.47M +52.1% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $6.12M +$3.23M +111% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $3.35M +$1.46M +77% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $2.48M +$317K +14.6% Dec 31, 2022 10-K 2024-03-25
Q3 2022 $2.82M -$243K -7.93% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $2.9M -$1.7M -37% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $1.89M -$2.06M -52.2% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $2.16M -$2.89M -57.1% Dec 31, 2021 10-K 2023-03-03
Q3 2021 $3.06M -$6.05M -66.4% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $4.6M -$4.86M -51.4% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $3.95M -$4.24M -51.8% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $5.05M -$271K -5.09% Dec 31, 2020 10-K 2022-03-10
Q3 2020 $9.11M +$3.14M +52.5% Sep 30, 2020 10-Q 2020-10-30
Q2 2020 $9.46M +$2.84M +42.8% Jun 30, 2020 10-Q 2020-07-29
Q1 2020 $8.2M +$3.51M +74.9% Mar 31, 2020 10-Q 2020-04-27
Q4 2019 $5.32M +$2.65M +99.4% Dec 31, 2019 10-K 2021-03-12
Q3 2019 $5.97M +$2.58M +75.9% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $6.63M +$2.67M +67.6% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $4.69M +$402K +9.38% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $2.67M -$1.77M -39.8% Dec 31, 2018 10-K 2020-03-12
Q3 2018 $3.4M -$1.06M -23.8% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 $3.95M -$6.22M -61.1% Jun 30, 2018 10-Q 2018-07-30
Q1 2018 $4.28M -$6.09M -58.7% Mar 31, 2018 10-Q 2018-05-03
Q4 2017 $4.43M +$556K +14.3% Dec 31, 2017 10-K 2019-03-15
Q3 2017 $4.46M +$2.02M +82.5% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $10.2M +$1.1M +12.2% Jun 30, 2017 10-Q 2017-08-01
Q1 2017 $10.4M -$3.9M -27.3% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 $3.88M -$6.26M -61.7% Dec 31, 2016 10-K 2018-03-01
Q3 2016 $2.44M -$8.51M -77.7% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 $9.07M +$1.92M +26.8% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 $14.3M +$11.1M +347% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 $10.1M +$5.37M +113% Dec 31, 2015 10-K 2017-03-06
Q3 2015 $11M +$5.02M +84.5% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $7.15M -$191K -2.6% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 $3.19M -$3.38M -51.4% Mar 31, 2015 10-Q 2015-05-05
Q4 2014 $4.76M +$128K +2.76% Dec 31, 2014 10-K 2016-03-11
Q3 2014 $5.94M -$1.32M -18.2% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 $7.34M +$658K +9.84% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 $6.57M -$1.87M -22.1% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 $4.64M -$1.71M -27% Dec 31, 2013 10-K 2015-03-12
Q3 2013 $7.26M -$1.75M -19.4% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 $6.68M +$102K +1.55% Jun 30, 2013 10-Q 2013-08-01
Q1 2013 $8.44M +$3.3M +64.1% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 $6.35M +$2.6M +69.4% Dec 31, 2012 10-K 2014-03-07
Q3 2012 $9M +$4.67M +108% Sep 30, 2012 10-Q 2012-11-07
Q2 2012 $6.58M +$2.71M +69.9% Jun 30, 2012 10-Q 2012-08-02
Q1 2012 $5.14M Mar 31, 2012 10-Q 2012-05-03
Q4 2011 $3.75M +$865K +30% Dec 31, 2011 10-K 2013-03-11
Q3 2011 $4.34M Sep 30, 2011 10-Q 2011-11-01
Q2 2011 $3.87M Jun 30, 2011 10-Q 2011-08-09
Q4 2010 $2.88M Dec 31, 2010 10-K 2012-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.